A carregar...
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
INTRODUCTION: HE4 is a novel biomarker for ovarian cancer. This study measured HE4 and CA125 levels in women with benign gynecologic disorders. METHODS: Sera were obtained from women prior to surgery for a pelvic mass and HE4 and CA125 levels were determined. The proportions of patients with elevate...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3985608/ https://ncbi.nlm.nih.gov/pubmed/22284961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2011.12.029 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|